J&J vows appeal after US jury hits it with record $1.5 billion talc cancer award

Johnson & Johnson Hit With Record $1.5 Billion US Verdict Over Talc Cancer Claim - Johnson & Johnson (NYSE:JNJ)

Baltimore jury awards $1.5 billion against Johnson & Johnson in record talc-asbestos mesothelioma verdict; company plans to appeal.

J&J vows appeal after US jury hits it with record $1.5 billion talc cancer award

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her peritoneal mesothelioma, a form of cancer.

Johnson & Johnson pledges appeal following record $1.5B U.S. jury verdict in talc cancer case

Understood! Please provide the article you'd like a meta description for.

J&J Talc Jury Awards $1.56 Billion to Asbestos Cancer Victim

Johnson & Johnson was ordered to pay about $1.56 billion to a Maryland woman who blamed the company’s talc-based baby powder for causing her asbestos-linked cancer, the largest such jury verdict for an individual in 15 years of litigation.

Over $1.5 Billion Baltimore Verdict Holds Johnson & Johnson Liable Over Iconic Baby Powder

BALTIMORE--(BUSINESS WIRE)--Dec 22, 2025-

Baltimore Jury Hits Johnson & Johnson With $1.5B Talc Verdict

A jury in Baltimore City Circuit Court awarded $59.84 million to plaintiff Cherie Craft, then added $1 billion in punitive damages against Johnson & Johnson and its subsidiary, Pecos River.